ISPE European Conference Announces Pharma 4.0
The International Society for Pharmaceutical Engineering (ISPE) announced its Europe Pharma 4.0 Conference, taking place November 23 – 24, 2017 in Verona, Italy.
The International Society for Pharmaceutical Engineering (ISPE) announced its Europe Pharma 4.0 Conference, taking place November 23 – 24, 2017 in Verona, Italy. Organized in partnership with the ISPE Italy Affiliate, the conference will focus on preparing the pharmaceutical and biopharmaceutical industry for a full transition to an end-to-end integrated computerized system throughout the manufacturing process.
Founded by the ISPE Europe Affiliates’ special interest group (SIG), From Industry 4.0 to Pharma 4.0, the two-day event features an education program focused on core topics, including automation, analytics, end-to-end integration, and workforce 4.0. Attendees will gain insight into a new world of manufacturing, engage in dialogue with peer groups and senior industry leaders, and learn new manufacturing applications, models, and solutions
“Shifting the paradigm to Pharma 4.0 and focusing on the issues specifically surrounding pharmaceutical priorities will lead to improvements in productivity, quality, and security of the supply chain,” said John Bournas, ISPE CEO and president, in a company press release. “The conference will explore the effects of this shift and how the industry will prepare for this next generational challenge.”
Source: ISPE
Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines
April 30th 2024In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.
Drug Solutions Podcast: Gliding Through the Ins and Outs of the Pharma Supply Chain
November 14th 2023In this episode of the Drug Solutions podcast, Jill Murphy, former editor, speaks with Bourji Mourad, partnership director at ThermoSafe, about the supply chain in the pharmaceutical industry, specifically related to packaging, pharma air freight, and the pressure on suppliers with post-COVID-19 changes on delivery.
Understanding the Variability in Bioburden Test Results in Biomanufacturing
May 7th 2025This article explores the impact of test volume, microbial distribution, and dilution errors on bioburden testing variability. It presents statistical approaches to estimate percentage error and discusses strategies to optimize microbial enumeration techniques in biopharmaceutical quality control.
Trump Directs FDA, EPA to Reduce Regulatory Barriers to Domestic Pharma Manufacturing
May 7th 2025The White House is instructing FDA to increase fees for and inspections of foreign drug manufacturing plants and reduce the time required to approve such sites that will be newly constructed in the US.
